Predictive Biosciences and Affinity Life Sciences Collaborate in the Development of Unique Biomarker Assays
Summary
Press Releases Affinity Life Sciences Press Release Share Blog Receive press releases from Affinity Life Sciences: By Email PDF Version RSS Feeds: Predictive Biosciences and Affinity Life Sciences Collaborate in the Development of Unique Biomarker Assays This collaboration provides Predictive with additional support services by utilizing Affinity’s expertise in biomarker immunoassay development.Predictive Biosciences, having a well established R&D and CLIA testing facilities, will expand its cancer diagnostic menu with support from Affinity.Affinity specializes in biomarker and immunochemistry assay design, development, and commercialization for research use or under cGMP conditions.They are an outstanding organization with a significant product pipeline and are well prepared for growth,” said Tod Gavron, President of Affinity.About Affinity Life Sciences, Inc.Affinity Life Sciences is a Contract Research and Manufacturing Organization providing R&D, testing, manufacturing, and commercialization services for the diagnostic and pharmaceutical industries.Affinity specializes in biomarker and immunochemistry assay design, development, and commercialization for research use or under cGMP conditions.